NCT05978609View on ClinicalTrials.gov

Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2026

Conditions
Cholangiocarcinoma Non-resectable
Interventions
DRUG

Candonilimab

Candonilimab 10mg/kg, Ivgtt，Q3W，Every 21 days is a cycle, administered on the first day of each cycle, and used continuously；

DRUG

Cisplatin

Cisplatin，25mg/m2，Ivgtt，Dosing on days 1 and 8，Every 21 days is a cycle, administered on the first day of each cycle, and used continuously；

DRUG

Gemcitabine

gemcitabine 1000mg/m2，Ivgtt，Dosing on days 1 and 8，Every 21 days is a cycle, administered on the first day of each cycle, and used continuously；

Trial Locations (1)

610041

RECRUITING

West China Hospital, Sichuan University, Chengdu

All Listed Sponsors
lead

West China Hospital

OTHER